A groundbreaking pharmacogenetic tool has been developed to predict chemotherapy side effects based on a patient’s genetic profile. Tested in NSCLC patients, the ANTIBLASTIC DRUG MULTIPANEL PLATFORM helps personalize treatment, improving safety and effectiveness. The tool has potential for proactive healthcare beyond cancer.
Topics
